The coming-of-age of bedaquiline: a tale with an open ending
- PMID: 34112716
- DOI: 10.1183/13993003.00066-2021
The coming-of-age of bedaquiline: a tale with an open ending
Conflict of interest statement
Conflict of interest: L. Guglielmetti is the co-principal investigator of two MSF-sponsored clinical trials testing MDR-TB regimens including bedaquiline. Conflict of interest: F. Varaine is the project leader of two MSF-sponsored clinical trials testing MDR-TB regimens including bedaquiline.
Comment on
-
Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country.Eur Respir J. 2021 Jun 10;57(6):2002544. doi: 10.1183/13993003.02544-2020. Print 2021 Jun. Eur Respir J. 2021. PMID: 33334942
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources